Sat 26 Oct 2024 ▪
3 min read
▪
by
Doliprane, the star medication against fever and pain, is making headlines due to its controversial sale to an American investment fund. The affair has sparked an outcry, particularly because of a one-time bonus of 200 million euros paid to its CEO.